Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Drew Kern to Subthalamic Nucleus

This is a "connection" page, showing publications Drew Kern has written about Subthalamic Nucleus.

 
Connection Strength
 
 
 
3.173
 
  1. Thompson JA, Radcliffe EM, Ojemann S, Kramer DR, David-Gerecht P, Case M, Zarns C, Holt-Becker A, Raike RS, Baumgartner AJ, Kern DS. Unipolar recordings of beta power inform initial programming of the subthalamic nucleus in Parkinson's disease. Parkinsonism Relat Disord. 2025 Dec; 141:108078.
    View in: PubMed
    Score: 0.848
  2. Kern D, Korsmo M, Baumgartner AJ, Kramer D, Ojemann S, Case M, Holt-Becker AB, Raike R, Thompson JA. Methylphenidate effects on a clinically informative oscillatory signal within the subthalamic nucleus in Parkinson's disease during deep brain stimulation programming. Brain Stimul. 2022 May-Jun; 15(3):747-749.
    View in: PubMed
    Score: 0.669
  3. Kern DS, Fasano A, Thompson JA, Abosch A, Ojemann S, Munhoz RP. Constant Current versus Constant Voltage: Clinical Evidence Supporting a Fundamental Difference in the Modalities. Stereotact Funct Neurosurg. 2021; 99(2):171-175.
    View in: PubMed
    Score: 0.605
  4. Baumgartner AJ, Hirt L, Amara AW, Kern DS, Thompson JA. Diurnal fluctuations of subthalamic nucleus local field potentials follow naturalistic sleep-wake behavior in Parkinson's disease. Sleep. 2025 Jun 13; 48(6).
    View in: PubMed
    Score: 0.207
  5. Radcliffe EM, Baumgartner AJ, Kern DS, Al Borno M, Ojemann S, Kramer DR, Thompson JA. Oscillatory beta dynamics inform biomarker-driven treatment optimization for Parkinson's disease. J Neurophysiol. 2023 06 01; 129(6):1492-1504.
    View in: PubMed
    Score: 0.180
  6. Lewis S, Radcliffe E, Ojemann S, Kramer DR, Hirt L, Case M, Holt-Becker AB, Raike R, Kern DS, Thompson JA. Pilot Study to Investigate the Use of In-Clinic Sensing to Identify Optimal Stimulation Parameters for Deep Brain Stimulation Therapy in Parkinson's Disease. Neuromodulation. 2024 Apr; 27(3):509-519.
    View in: PubMed
    Score: 0.176
  7. Tekriwal A, Baker S, Christensen E, Petersen-Jones H, Tien RN, Ojemann SG, Kern DS, Kramer DR, Felsen G, Thompson JA. Quantifying neuro-motor correlations during awake deep brain stimulation surgery using markerless tracking. Sci Rep. 2022 10 27; 12(1):18120.
    View in: PubMed
    Score: 0.173
  8. Baumgartner AJ, Thompson JA, Kern DS, Ojemann SG. Novel targets in deep brain stimulation for movement disorders. Neurosurg Rev. 2022 Aug; 45(4):2593-2613.
    View in: PubMed
    Score: 0.167
  9. Kern DS, Uy D, Rhoades R, Ojemann S, Abosch A, Thompson JA. Discrete changes in brain volume after deep brain stimulation in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 2020 09; 91(9):928-937.
    View in: PubMed
    Score: 0.147
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)